PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Clinical trial indicates gabapentin is safe and effective for treating alcohol dependence

2013-11-05
(Press-News.org) Contact information: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Clinical trial indicates gabapentin is safe and effective for treating alcohol dependence

LA JOLLA, CA – November 4, 2013 – The generic drug gabapentin, which is already widely prescribed for epilepsy and some kinds of pain, appears to be safe and effective in the treatment of alcohol dependence. The finding comes from a 150-patient randomized, placebo-controlled, double blind clinical trial conducted by scientists at The Scripps Research Institute (TSRI).

"Gabapentin's effect on drinking outcomes is at least as large or greater than those of existing FDA-approved treatments," said Barbara J. Mason, Pearson Family Professor and co-director of the Pearson Center for Alcoholism and Addiction Research at TSRI, who led the new research. "Plus it's the only medication shown to improve sleep and mood in people who are quitting or reducing their drinking, and it's already widely used in primary care—that's an appealing combination."

The new research was published by the journal JAMA Internal Medicine on November 4, 2013.

Reducing Cravings, Depression, Sleeplessness

As a relatively safe, effective and well-tolerated drug, gabapentin has the potential to fill a large gap in the treatment of alcohol dependence. About eight and a half-million Americans are thought to have the condition, yet each year only a tiny fraction of them are prescribed one of the FDA-approved medications for alcohol dependence, due in part to the limitations of the existing drugs used for treatment.

The lack of treatment is striking in light of alcoholism's enormous adverse impact on society. In addition to its other effects on the lives of individuals and their families, alcoholism promotes cancer, liver disease, strokes and heart attacks, as well as various other disabilities. Worldwide, about one out of 25 deaths is attributable to alcohol misuse.

In the new study, Mason and her colleagues randomly assigned each of 150 recently abstinent people with alcohol dependence to be treated with 900 mg or 1,800 mg of gabapentin or with a look-alike placebo. Over 12 weeks of treatment, the high-dose group ended up refraining from heavy drinking twice as often as the placebo group (45% vs. 23%) and entirely abstained four times as often (17% vs. 4%). The drug also significantly reduced the number of drinks consumed, as well as patient reports of cravings, depression and sleeplessness. None of the treated patients reported serious side effects.

Patients who received the lower, 900-mg dose of gabapentin showed intermediate benefits compared to the high-dose group, likely reflecting what clinicians call a "dose-response effect"—a good indication that the treatment really is working.

"I think that we can now have confidence in the pharmacological effect of this drug," Mason said.

Filling a Gap

Two FDA-approved therapies for alcohol dependence have been around for decades. The first, disulfiram (Antabuse®), interferes with the body's normal enzymatic breakdown of alcohol, making drinking an unpleasant experience. The second, naltrexone (ReVia®, Vivitrol®), blocks the opioid brain-cell receptors that help mediate the sense of reward during drinking.

Both treatments aim to blunt the pleasure-seeking motivation that helps initiate alcohol dependence. But they are relatively ineffective against the anxiety, depression, sleeplessness and other protracted withdrawal symptoms that help maintain alcoholism once it has been established. They are also, by design, somewhat unpleasant—which often discourages patients from using them.

A newer drug, acamprosate (Campral®), the only other medication approved by FDA for alcoholism treatment, does aim to normalize dysregulation in brain stress systems following acute withdrawal, similar to gabapentin. But it has shown only modest benefits on the whole in clinical trials, with no efficacy noted for mood or sleep.

Gabapentin has a favorable safety profile and appears to work by normalizing levels of the neurotransmitter GABA in an emotion-mediating part of the brain called the amygdala, thereby reducing anxiety and other stress-related withdrawal symptoms. A previous, proof-of-concept study of gabapentin by Mason's group also found effects like those reported in this study in patients with cannabis dependence.

Gabapentin's quieting effect on overactive brain areas has led to its approval by the FDA for treating epilepsy and neuropathic pain. It is also now widely prescribed "off-label" for other pain-related conditions, including migraines.

"I'm excited about the possibility that now more people will get treatment," said Mason. "We really need to do more about treating alcohol dependence."



INFORMATION:



Other contributors to the study, "Gabapentin Treatment for Alcohol Dependence: A Randomized Controlled Trial," were Susan Quello and Vivian Goodell of TSRI; and physicians Farhad Shadan, Mark Kyle and Adnan Begovic of the Scripps Clinic and Scripps Green Hospital in La Jolla, California.

The study was supported by funding from the National Institute on Alcohol Abuse and Alcoholism (grant R37AA014028), a MERIT Award to Dr. Mason from the National Institutes of Health.



ELSE PRESS RELEASES FROM THIS DATE:

Astronomers answer key question: How common are habitable planets?

2013-11-05
Astronomers answer key question: How common are habitable planets? Based on Kepler data, 1 in 5 sun-like stars has Earth-size planet in habitable zone ...

Elusive bay cat caught on camera

2013-11-05
Elusive bay cat caught on camera First time 5 species of wild cat spotted in a Borneo forest The world's least known cat has been caught on camera in a previously unsurveyed rainforest by scientists from the Zoological Society of London (ZSL) and Imperial ...

New strep throat risk score brings patient data and big data together to potentially reduce unnecess

2013-11-05
New strep throat risk score brings patient data and big data together to potentially reduce unnecess Boston, Mass., November 4, 2013 –A new risk measure called a "home score" could save a patient with symptoms of strep throat a trip to the doctor, ...

Race and romance online

2013-11-05
Race and romance online Study of internet dating suggests racial barriers can be overcome Usually, research findings on the state of U.S. race relations are pretty bleak. But a study of online dating by UC San Diego sociologist Kevin Lewis suggests ...

Overhaul of medical education to address primary care physician shortage recommended by national panel

2013-11-05
Overhaul of medical education to address primary care physician shortage recommended by national panel Blue Ribbon Commission for the Advancement of Osteopathic Medical Education issues ...

UCSF researchers offer solutions to looming health-care provider shortage

2013-11-05
UCSF researchers offer solutions to looming health-care provider shortage Authors say increasing scope of practice for non-physician health professionals will increase coverage Thanks to a wave of aging baby boomers, epidemics of diabetes ...

Imaging studies may predict tumor response to anti-angiogenic drugs

2013-11-05
Imaging studies may predict tumor response to anti-angiogenic drugs Study confirms that vascular normalization is the way these drugs improve patient survival Advanced imaging techniques may be able to distinguish which patients' tumors will respond ...

Scientists study 'fishy' behavior to solve an animal locomotion mystery

2013-11-05
Scientists study 'fishy' behavior to solve an animal locomotion mystery A quirk of nature has long baffled biologists: Why do animals push in directions that don't point toward their goal, like the side-to-side sashaying of a running lizard or cockroach? An engineer ...

Eating disorders more common in males than realized

2013-11-05
Eating disorders more common in males than realized Broader diagnostic criteria could help identify illness in boys Boston−November 4, 2013 - Parents and doctors assume eating disorders very rarely affect males. However, a study of 5,527 ...

Foreign-educated health workers play vital role in US health system

2013-11-05
Foreign-educated health workers play vital role in US health system Changes may be needed to stabilize workforce Foreign-educated and foreign-born health professionals play a vital role in the U.S. health care workforce, but strategic shifts such as changes in immigration laws ...

LAST 30 PRESS RELEASES:

Study tracks chromium chemistry in irradiated molten salts

Scientists: the beautiful game is a silver bullet for global health

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

[Press-News.org] Clinical trial indicates gabapentin is safe and effective for treating alcohol dependence